403 related articles for article (PubMed ID: 17668560)
1. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
Manosuthi W; Ruxrungtham K; Likanonsakul S; Prasithsirikul W; Inthong Y; Phoorisri T; Sungkanuparph S
Clin Infect Dis; 2007 Jan; 44(1):141-4. PubMed ID: 17143831
[TBL] [Abstract][Full Text] [Related]
3. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
[TBL] [Abstract][Full Text] [Related]
4. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD
Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.
Getahun A; Tansuphasawadikul S; Desakorn V; Dhitavat J; Pitisuttithum P
J Med Assoc Thai; 2006 Sep; 89(9):1472-8. PubMed ID: 17100387
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study.
Anekthananon T; Ratanasuwan W; Techasathit W; Sonjai A; Suwanagool S
J Med Assoc Thai; 2004 Jul; 87(7):760-7. PubMed ID: 15521230
[TBL] [Abstract][Full Text] [Related]
7. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
[TBL] [Abstract][Full Text] [Related]
8. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
10. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
[TBL] [Abstract][Full Text] [Related]
11. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K
Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.
Kiertiburanakul S; Khongnorasat S; Rattanasiri S; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):237-43. PubMed ID: 17375626
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
van Oosterhout JJ; Bodasing N; Kumwenda JJ; Nyirenda C; Mallewa J; Cleary PR; de Baar MP; Schuurman R; Burger DM; Zijlstra EE
Trop Med Int Health; 2005 May; 10(5):464-70. PubMed ID: 15860093
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
Hosseinipour MC; Corbett AH; Kanyama C; Mshali I; Phakati S; Rezk NL; van der Horst C; Kashuba AD
AIDS; 2007 Jan; 21(1):59-64. PubMed ID: 17148968
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
Tin EE; Bowonwatanuwong C; Desakorn V; Wilairatana P; Krudsood S; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):362-9. PubMed ID: 15916042
[TBL] [Abstract][Full Text] [Related]
16. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
[TBL] [Abstract][Full Text] [Related]
17. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
[TBL] [Abstract][Full Text] [Related]
18. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
Manosuthi W; Kiertiburanakul S; Chaovavanich A; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
[TBL] [Abstract][Full Text] [Related]
19. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy].
Schwietert M; Battegay M
Dtsch Med Wochenschr; 1999 Jan; 124(3):45-8. PubMed ID: 9987485
[TBL] [Abstract][Full Text] [Related]
20. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program.
Idigbe EO; Adewole TA; Eisen G; Kanki P; Odunukwe NN; Onwujekwe DI; Audu RA; Araoyinbo ID; Onyewuche JI; Salu OB; Adedoyin JA; Musa AZ
J Acquir Immune Defic Syndr; 2005 Sep; 40(1):65-9. PubMed ID: 16123684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
